| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Jared Moskowitz FL23 | 2 | 2 | +$0 | Sold Mar 23, 26 |
| Gilbert Cisneros CA31 | 1 | 4 | −$24.0K | Sold Mar 13, 26 |
| Julie Johnson TX32 | 3 | 6 | −$24.0K | Sold Dec 18, 25 |
| Valerie Hoyle OR04 | 1 | 1 | +$0 | Sold Sep 23, 25 |
| Jefferson Shreve IN06 | 1 | 1 | +$0 | Sold May 12, 25 |
| Julia Letlow LA05 | 1 | 1 | +$0 | Sold Apr 22, 25 |
| Rob Bresnahan PA08 | 2 | −$16.0K | Sold Feb 25, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Mar 23, 26 | Jared Moskowitz FL23 | Child | Sell | $1,001 - $15,000 | Apr 30, 26 (38d) | |
| Mar 23, 26 | Jared Moskowitz FL23 | Self | Sell | $1,001 - $15,000 | Apr 30, 26 (38d) | |
| Mar 13, 26 | Gilbert Cisneros CA31 | Self | Sell | $1,001 - $15,000 | Apr 7, 26 (25d) | |
| Dec 19, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Jan 12, 26 (24d) | |
| Dec 18, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Jan 15, 26 (28d) | |
| Nov 13, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Dec 11, 25 (28d) | |
| Nov 12, 25 | Gilbert Cisneros CA31 | Self | Sell | $1,001 - $15,000 | Dec 15, 25 (33d) | |
| Sep 25, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Oct 7, 25 (12d) | |
| Sep 23, 25 | Julie Johnson TX32 | Joint | Buy | $1,001 - $15,000 | Aug 5, 26 (316d) | |
| Sep 23, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Aug 5, 26 (316d) | |
| Sep 23, 25 | Valerie Hoyle OR04 | Spouse | Sell | $1,001 - $15,000 | Oct 10, 25 (17d) | |
| Aug 14, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Sep 11, 25 (28d) | |
| Aug 5, 25 | Gilbert Cisneros CA31 | Self | Sell (part) | $1,001 - $15,000 | Sep 12, 25 (38d) | |
| May 15, 25 | Jared Moskowitz FL23 | Child | Buy | $1,001 - $15,000 | Jun 27, 25 (43d) | |
| May 15, 25 | Jared Moskowitz FL23 | Self | Buy | $1,001 - $15,000 | Jun 27, 25 (43d) | |
| May 12, 25 | Jefferson Shreve IN06 | Self | Sell | $15,001 - $50,000 | Jun 22, 25 (41d) | |
| Apr 22, 25 | Julia Letlow LA05 | Self | Sell | $1,001 - $15,000 | Jan 13, 26 (266d) | |
| Mar 19, 25 | Julie Johnson TX32 | Joint | Buy | $1,001 - $15,000 | Apr 14, 25 (26d) | |
| Mar 3, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | Apr 14, 25 (42d) | |
| Feb 25, 25 | Rob Bresnahan PA08 | Self | Sell | $1,001 - $15,000 | Mar 27, 25 (30d) | |
| Feb 24, 25 | Jefferson Shreve IN06 | Self | Buy | $15,001 - $50,000 | Mar 9, 25 (13d) | |
| Jan 24, 25 | Gilbert Cisneros CA31 | Self | Sell (part) | $1,001 - $15,000 | Feb 11, 25 (18d) | |
| Jan 15, 25 | Julie Johnson TX32 | Joint | Buy | $1,001 - $15,000 | Feb 12, 25 (28d) | |
| Jan 13, 25 | Rob Bresnahan PA08 | Joint | Sell | $1,001 - $15,000 | Feb 13, 25 (31d) | |
| Oct 29, 24 | Valerie Hoyle OR04 | Spouse | Buy | $1,001 - $15,000 | Sep 12, 25 (318d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Neville EverettOfficer | Sale at price 284.05 per share. | 617 | $175.26K |
| Aug 31, 2026 | Evanko Brian CChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 3.1K | — |
| Aug 17, 2026 | Jones Nicole S.Officer | Sale at price 279.61 per share. | 2.7K | $748.52K |
| Aug 4, 2026 | Jones Nicole S.Officer | Conversion of Exercise of derivative security at price 192.02 per share. | 15.3K | $2.95M |
| Aug 3, 2026 | Jones Nicole S.Officer | Sale at price 276.27 per share. | 19.4K | $5.37M |
| Jun 11, 2026 | Kates Jamie GOfficer | Sale at price 298.61 per share. | 899 | $268.45K |
| Jun 11, 2026 | Kates Jamie GOfficer | Conversion of Exercise of derivative security at price 152.89 per share. | 899 | $137.45K |
| May 12, 2026 | Cordani David MChief Executive Officer | Conversion of Exercise of derivative security at price 149.14 - 197.35 per share. | 212.5K | $36.21M |
| May 11, 2026 | Cordani David MChief Executive Officer | Sale at price 286.83 - 298.53 per share. | 201.9K | $59.11M |
| Apr 21, 2026 | Mcclellan Mark BDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Ozuah PhillipDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Hathi NeeshaDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Ross Kimberly ADirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Kurian GeorgeDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Wiseman Eric CDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Hennigan Michael JDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Foss Eric J.Director | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Mazzarella Kathleen M.Director | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Apr 21, 2026 | Zarcone Donna FDirector | Stock Award(Grant) at price 0.00 per share. | 782 | — |
| Mar 1, 2026 | Neville EverettOfficer | Sale at price 288.91 per share. | 1.7K | $496.64K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.4 | 5.7 | -8.0 | 8.9 | -4.5 | -0.6 | 1.2 | -1.1 | -1.5 | 4.2 | +2.9% | ||
| 2025 | 6.5 | 5.0 | 6.5 | 3.4 | -6.9 | 4.4 | -19.1 | 12.5 | -4.2 | -15.2 | 13.4 | -0.7 | −0.3% |
| 2024 | 0.5 | 11.7 | 8.0 | -1.7 | -3.5 | -4.1 | 5.5 | 3.8 | -4.2 | -9.1 | 7.3 | -18.3 | −7.8% |
| 2023 | -4.4 | -7.8 | -12.5 | -0.9 | -2.3 | 13.4 | 5.2 | -6.4 | 3.6 | 8.1 | -15.0 | 13.9 | −9.6% |
| 2022 | 0.4 | 3.2 | 0.8 | 3.0 | 8.7 | -1.8 | 4.5 | 2.9 | -2.1 | 16.4 | 1.8 | 0.7 | +44.3% |
| 2021 | 4.3 | -3.3 | 15.2 | 3.0 | 4.0 | -8.4 | -3.2 | -7.8 | -5.4 | 6.7 | -10.2 | 19.7 | +10.3% |
| 2020 | -5.9 | -4.9 | -3.1 | 10.5 | 0.8 | -4.9 | -8.0 | 2.7 | -4.5 | -1.4 | 25.3 | -0.5 | +1.8% |
| 2019 | 5.2 | -12.7 | -7.8 | -1.2 | -6.8 | 6.4 | 7.9 | -9.4 | -1.4 | 17.6 | 12.0 | 2.3 | +7.7% |
| 2018 | 2.6 | -6.0 | -14.4 | 2.4 | -1.4 | 0.3 | 5.6 | 5.0 | 10.6 | 2.7 | 4.5 | -15.0 | −6.5% |
| 2017 | 9.6 | 1.8 | -1.6 | 6.7 | 3.1 | 3.8 | 3.7 | 4.9 | 2.7 | 5.5 | 7.4 | -4.1 | +52.3% |
| 2016 | -8.7 | 4.5 | -1.7 | 0.9 | -7.5 | -0.1 | 0.8 | -0.5 | 1.6 | -8.8 | 13.4 | -1.0 | −8.8% |
| 2015 | 3.8 | 13.9 | 6.4 | -3.7 | 13.0 | 15.0 | -11.1 | -2.3 | -4.1 | -0.7 | 0.7 | 8.4 | +42.2% |
| 2014 | -1.3 | -7.8 | 5.2 | -4.4 | 12.2 | 2.4 | -2.1 | 5.1 | -4.1 | 9.8 | 3.3 | 0.0 | +17.6% |
| 2013 | 9.1 | 0.2 | 6.7 | 6.1 | 2.6 | 6.8 | 7.4 | 1.1 | -2.3 | 0.2 | 13.6 | 0.0 | +63.6% |
| 2012 | 6.7 | -1.6 | 11.7 | -6.1 | -5.0 | 0.2 | -8.5 | 13.6 | 3.1 | 8.1 | 2.5 | 2.3 | +27.3% |
| 2011 | 14.6 | 0.1 | 5.3 | 5.8 | 6.5 | 3.1 | -3.2 | -6.1 | -10.3 | 5.7 | -0.2 | -5.0 | +14.6% |
| 2010 | -4.3 | 1.5 | 6.8 | -12.4 | 4.4 | -7.2 | -1.0 | 4.7 | 11.0 | -1.7 | 4.7 | -0.4 | +3.9% |
| 2009 | 3.0 | -9.2 | 11.6 | 12.1 | 12.5 | 8.7 | 17.9 | 3.6 | -4.6 | -0.9 | 15.2 | 9.9 | +109.3% |
| 2008 | -8.4 | -9.4 | -9.0 | 5.3 | -4.9 | -12.8 | 4.6 | 13.1 | -18.9 | -52.0 | -25.7 | 39.1 | −68.6% |
| 2007 | 0.6 | 7.6 | 0.1 | 9.1 | 7.7 | -6.5 | -1.1 | 0.1 | 3.1 | -1.5 | 2.1 | 0.2 | +22.5% |
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Buy / hold / sell counts